Literature DB >> 28774877

How I treat pediatric venous thromboembolism.

Guy Young1.   

Abstract

The incidence of pediatric venous thromboembolism (VTE) has been increasing significantly over the past decade in part as a result of increased recognition of this serious disorder but more so because of the increased use of central venous catheters and other technological advancements involved in the care of ill children. Management of pediatric VTE is a complex undertaking, considering that the vast majority of children who develop this complication have serious underlying medical disorders. Although the incidence is rising, in comparison with adults, this remains a relatively rare disorder, and as such, large-scale clinical trials have not been completed, rendering management decisions to be based on extrapolation from adult data and the experience of the treating physician. Clearly, both are fraught with problems. Thus, day-to-day management remains more art than science until such time that the results from clinical trials (many of which are under way) become available. This edition of "How I Treat" describes the author's experience in managing 3 common scenarios that one may encounter in pediatric thrombosis and suggests a logical approach to such situations. Furthermore, the author provides 3 algorithms to help guide management decisions.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28774877      PMCID: PMC5813720          DOI: 10.1182/blood-2017-04-742320

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years.

Authors:  W Zenz; F Arlt; S Sodia; A Berghold
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

Review 2.  Anticoagulants in children and adolescents.

Authors:  Guy Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

3.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa study.

Authors:  Jacqueline M L Halton; Thorsten Lehr; Lisa Cronin; Maximilian T Lobmeyer; Sebastian Haertter; Mark Belletrutti; Lesley G Mitchell
Journal:  Thromb Haemost       Date:  2016-06-30       Impact factor: 5.249

5.  Catheter-directed thrombolysis with recombinant tissue plasminogen activator for acute pulmonary embolism after fontan operation.

Authors:  A Beitzke; G Zobel; W Zenz; A Gamillscheg; J I Stein
Journal:  Pediatr Cardiol       Date:  1996 Nov-Dec       Impact factor: 1.655

6.  Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Authors:  N A Goldenberg; T Abshire; P J Blatchford; L Z Fenton; J L Halperin; W R Hiatt; C M Kessler; J M Kittelson; M J Manco-Johnson; A C Spyropoulos; P G Steg; N V Stence; A G G Turpie; S Schulman
Journal:  J Thromb Haemost       Date:  2015-08-11       Impact factor: 5.824

7.  FondaKIDS II: long-term follow-up data of children receiving fondaparinux for treatment of venous thromboembolic events.

Authors:  Richard H Ko; Carlo Michieli; Jessica L Lira; Guy Young
Journal:  Thromb Res       Date:  2014-07-23       Impact factor: 3.944

Review 8.  Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review.

Authors:  Kelly R Culwell; Kathryn M Curtis
Journal:  Contraception       Date:  2009-06-10       Impact factor: 3.375

9.  Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

Authors:  Leslie Raffini; Yuan-Shung Huang; Char Witmer; Chris Feudtner
Journal:  Pediatrics       Date:  2009-09-07       Impact factor: 7.124

10.  Successful rheolytic mechanical thrombectomy of cerebral venous thrombosis in a pediatric patient.

Authors:  Stylianos K Rammos; Jayme Phillips; Julian Lin; Kenneth Moresco; Sean Meagher
Journal:  J Neurosurg Pediatr       Date:  2012-11-30       Impact factor: 2.375

View more
  4 in total

1.  Homozygous protein C deficiency presenting as neonatal purpura fulminans: management with fresh frozen plasma, low molecular weight heparin and protein C concentrate.

Authors:  Hande Kizilocak; Nihal Ozdemir; Gürcan Dikme; Begum Koc; Tiraje Celkan
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

2.  Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size.

Authors:  Marady Hun; Min Xie; Zhou She; Amin S Abdirahman; Cuifang Li; Feifeng Wu; Senlin Luo; Phanna Han; Rithea Phorn; Pan Wu; Haiyan Luo; Keke Chen; Jidong Tian; Wuqing Wan; Chuan Wen
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

3.  Knowledge and Awareness of Venous Thromboembolism in Intensive Care Units in Zhejiang Province, China: A Cross-Sectional Survey.

Authors:  Jing Yan; Jia Zhou; Junhai Zhen; Li Li; Zhejiang Provincial Critical Care Clinical Research Group
Journal:  Med Sci Monit       Date:  2020-06-16

Review 4.  Updated recommendations for the treatment of venous thromboembolism.

Authors:  Junshik Hong; Seo-Yeon Ahn; Yoo Jin Lee; Ji Hyun Lee; Jung Woo Han; Kyoung Ha Kim; Ho-Young Yhim; Seung-Hyun Nam; Hee-Jin Kim; Jaewoo Song; Sung-Hyun Kim; Soo-Mee Bang; Jin Seok Kim; Yeung-Chul Mun; Sung Hwa Bae; Hyun Kyung Kim; Seongsoo Jang; Rojin Park; Hyoung Soo Choi; Inho Kim; Doyeun Oh
Journal:  Blood Res       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.